Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure

Background: Despite the recommendations from mainstream guidelines, the use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) for acute coronary syndrome (ACS) patients without heart failure (HF) is controversial, as its evidence is lacking in the era of repe...

Celý popis

Podrobná bibliografie
Hlavní autoři: Chen, Runzhen, Liu, Chen, Zhou, Peng, Li, Jiannan, Zhou, Jinying, Wang, Ying, Zhao, Xiaoxiao, Chen, Yi, Yan, Shaodi, Song, Li, Zhao, Hanjun, Yan, Hongbing
Médium: Online Článek Text
Jazyk:English
Vydáno: Frontiers Media S.A. 2022
Témata:
Pharmacology
On-line přístup:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/
https://www.ncbi.nlm.nih.gov/pubmed/35479321
http://dx.doi.org/10.3389/fphar.2022.663811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/
https://www.ncbi.nlm.nih.gov/pubmed/35479321
http://dx.doi.org/10.3389/fphar.2022.663811

Podobné jednotky